Comparison

Zeteletinib European Partner

Item no. TMO-T39688-5mg
Manufacturer TargetMol
CASRN 2216753-97-6
Amount 5 mg
Quantity options 10 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles COc1cc2cc(cnc2cc1OC)-c1ccc(CC(=O)Nc2cc(no2)C(C)(C)C(F)(F)F)cn1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias DS-5010,BOS-172738
Shipping Condition Cool pack
Available
Shipping Temperature
Cool pack
Storage Conditions
-20°
Molecular Weight
500, 478
Description
Zeteletinib (BOS-172738; DS-5010) is a highly potent and selective orally active inhibitor of the RET kinase. It demonstrates nanomolar potency against RET while exhibiting over 300-fold selectivity against VEGFR2. Zeteletinib exhibits remarkable efficacy against the wild-type RET, RET V804M/L gatekeeper mutants, as well as the frequently occurring oncogenic RET mutation M918T. Its antitumor activity is potent.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close